ATE520034T1 - Quantitative analyse einer biologischen probe unbekannter menge - Google Patents

Quantitative analyse einer biologischen probe unbekannter menge

Info

Publication number
ATE520034T1
ATE520034T1 AT03726433T AT03726433T ATE520034T1 AT E520034 T1 ATE520034 T1 AT E520034T1 AT 03726433 T AT03726433 T AT 03726433T AT 03726433 T AT03726433 T AT 03726433T AT E520034 T1 ATE520034 T1 AT E520034T1
Authority
AT
Austria
Prior art keywords
analyte
specimen
level
biological sample
quantitative analysis
Prior art date
Application number
AT03726433T
Other languages
English (en)
Inventor
Michael Wandell
Ilia Vinogradov
Original Assignee
Home Access Health Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Home Access Health Corp filed Critical Home Access Health Corp
Application granted granted Critical
Publication of ATE520034T1 publication Critical patent/ATE520034T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91188—Transferases (2.) transferring nitrogenous groups (2.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03726433T 2002-04-23 2003-04-23 Quantitative analyse einer biologischen probe unbekannter menge ATE520034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37462902P 2002-04-23 2002-04-23
PCT/US2003/012674 WO2003091736A2 (en) 2002-04-23 2003-04-23 Quantitative analysis of a biological sample of unknown quantity

Publications (1)

Publication Number Publication Date
ATE520034T1 true ATE520034T1 (de) 2011-08-15

Family

ID=29270528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726433T ATE520034T1 (de) 2002-04-23 2003-04-23 Quantitative analyse einer biologischen probe unbekannter menge

Country Status (7)

Country Link
US (3) US7479392B2 (de)
EP (2) EP1502117B1 (de)
AT (1) ATE520034T1 (de)
AU (1) AU2003228671B2 (de)
CA (1) CA2488933C (de)
ES (2) ES2371539T3 (de)
WO (1) WO2003091736A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611670B2 (en) 2002-04-23 2009-11-03 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
AU2003228671B2 (en) 2002-04-23 2008-11-20 Pwnhealth Chicago Llc Quantitative analysis of a biological sample of unknown quantity
US7569184B2 (en) 2002-04-23 2009-08-04 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
US20050065809A1 (en) * 2003-07-29 2005-03-24 Blackbaud, Inc. System and methods for maximizing donations and identifying planned giving targets
US8396670B2 (en) * 2004-08-16 2013-03-12 Venture Milling, Inc. Process, system and method for improving the determination of digestive effects upon an ingestable substance
SG11202111365QA (en) * 2019-05-17 2021-11-29 Somalogic Inc Controlling intersample analyte variability in complex biological matrices

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678757A (en) * 1985-04-11 1987-07-07 Smithkline Diagnostics, Inc. Device and method for whole blood separation and analysis
US4839296A (en) 1985-10-18 1989-06-13 Chem-Elec, Inc. Blood plasma test method
US5001067A (en) * 1989-09-18 1991-03-19 Nova Biomedical Corporation Determining the concentration of water soluble species in biological fluid
US5435970A (en) 1989-12-18 1995-07-25 Environmental Diagnostics, Inc. Device for analysis for constituents in biological fluids
DE4107689A1 (de) * 1991-03-09 1992-09-10 Fresenius Ag Verfahren und vorrichtung zur bestimmung des gesamteiweisses und des onkotischen druckes eiweisshaltiger koerperfluessigkeiten
JPH09500199A (ja) * 1993-02-23 1997-01-07 ザ・ゼネラル・ホスピタル・コーポレーション 親和性検定により検体濃度を測定するコンピュータ・システム及び方法
US6016345A (en) 1993-11-02 2000-01-18 Home Access Health Corporation Method and system for anonymously testing for a human malady
AU4036495A (en) * 1994-12-13 1996-06-20 Ortho Pharmaceutical Corporation Device and test kit for the detection of AIDS
WO1996028538A1 (en) * 1995-03-10 1996-09-19 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
ATE334392T1 (de) * 1995-05-09 2006-08-15 Beckman Coulter Inc Vorrichtungen und verfahren zur abtrennung zellulärer blutkomponenten von flüssigen blutanteilen
US5935775A (en) 1996-04-02 1999-08-10 Savjani; Gopal V. Whole blood analysis of prostate specific antigen spotted on a solid support
US6066464A (en) 1996-12-10 2000-05-23 Diagnostic Systems Laboratories, Inc. Immunoassay of IGF family of peptides, their binding proteins and related molecules in dried whole blood filter paper spots
US6265223B1 (en) * 1997-05-28 2001-07-24 Flexsite Diagnostics, Inc. Diagnostic assay
US6040135A (en) 1998-03-06 2000-03-21 Biosafe Laboratories, Inc. Method for correcting for blood volume in a serum analyte determination
CN1145027C (zh) * 1998-08-06 2004-04-07 光谱诊断公司 测定流体标本中至少一种分析物存在的分析化验装置和方法
JP3441993B2 (ja) * 1999-01-27 2003-09-02 松下電器産業株式会社 コレステロールセンサ
US6565738B1 (en) 1999-01-28 2003-05-20 Abbott Laboratories Diagnostic test for the measurement of analyte in abiological fluid
JP3643011B2 (ja) * 2000-05-18 2005-04-27 アークレイ株式会社 定量分析法
US20020055176A1 (en) * 2000-11-08 2002-05-09 Ray Robert A. Diagnostic assay system
US7392199B2 (en) * 2001-05-01 2008-06-24 Quest Diagnostics Investments Incorporated Diagnosing inapparent diseases from common clinical tests using Bayesian analysis
AU2003228671B2 (en) * 2002-04-23 2008-11-20 Pwnhealth Chicago Llc Quantitative analysis of a biological sample of unknown quantity

Also Published As

Publication number Publication date
US20090104636A1 (en) 2009-04-23
AU2003228671B2 (en) 2008-11-20
EP2287612B1 (de) 2016-09-21
US7479392B2 (en) 2009-01-20
EP1502117B1 (de) 2011-08-10
AU2003228671A1 (en) 2003-11-10
EP1502117A2 (de) 2005-02-02
US20120064555A1 (en) 2012-03-15
WO2003091736A2 (en) 2003-11-06
ES2371539T3 (es) 2012-01-04
CA2488933C (en) 2016-11-01
US8211703B2 (en) 2012-07-03
EP2287612A1 (de) 2011-02-23
CA2488933A1 (en) 2003-11-06
US8080425B2 (en) 2011-12-20
WO2003091736A3 (en) 2004-09-16
US20040018484A1 (en) 2004-01-29
ES2616842T3 (es) 2017-06-14

Similar Documents

Publication Publication Date Title
ES2153030T3 (es) Procedimiento de analisis cuantitativo del colesterol.
DE60024448D1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
DE60239968D1 (de) Sche
BR9611461A (pt) Aparelho de coleta de amostras, kit para a detecçao de um analisado em uma amostra, uso do aparelho de coleta de amostra e do kit e processo para detectar um analisado em uma amostra.
CA2322858A1 (en) Detection of analytes by fluorescent lanthanide chelates
NO20000970L (no) Fremgangsmõte og utstyr for rask analyse av analytter i biologiske stikkprøver
WO2003008933A3 (en) Test strip for a lateral flow assay
Yeung Chemical analysis of single human erythrocytes
ATE437365T1 (de) Probentestträger und verfahren zur prüfung von okkultem blut im stuhl
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
ATE496294T1 (de) Analyseset mit stechhilfe und messgerät
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
ATE520034T1 (de) Quantitative analyse einer biologischen probe unbekannter menge
BR9910009A (pt) Processos para coletar uma amostra derivada de um material fecal e para a detencção de sangue oculto em material fecal, e, kit de ensaio para teste de material fecal
JP2016533746A (ja) 多孔質基材における核酸増幅の検出
NO20034059L (no) Fremgangsmate for screening av pre-diabetiske tilstander og screening-reagens
EA200500157A1 (ru) Хранение и обнаружение нуклеиновой кислоты, нанесенной на твердый носитель
NO903748D0 (no) Fremgangsmaate ved enzymatisk bestemmelse av analyttkonsentrasjoner.
Lo et al. Reemphasizing the importance of commutability
EP3404418A2 (de) Diagnostischer streifen zur bestimmung der menge an sarkosin, kreatinin und wasserstoffperoxid in einer biologischen oder umweltprobe
KR960018583A (ko) 면역 분석법
황철진 A study to develop label-free biosensors for electrochemical detection of disease-specific biomarkers for early diagnosis
WO2004016802A3 (en) Methods and apparatus for preparing and assaying biological samples to determine protein concentration
Furuwatari et al. Clinical evaluation of RT-PCR method for detection of HCV-RNA: second report availability of RT-PCR system using PCR internal control for detection of HCV-RNA and the influence of interfering substances on the detection
Sreedhar et al. Determination of drugs in biological fluids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties